SCHEMBL900963

SCHEMBL900963

CCCCCc1csc2ncnc(N)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.44
TAOK1 Q7L7X3 3/20 0.43
MAP4K4 O95819 3/20 0.43
CLK2 P49760 3/20 0.43
GSK3A P49840 3/20 0.43
RPS6KA3 P51812 3/20 0.43
MAP4K2 Q12851 3/20 0.43
CLK4 Q9HAZ1 3/20 0.43
LCK P06239 2/20 0.43
MET P08581 2/20 0.43
DAPK3 O43293 2/20 0.43
PRKD3 O94806 2/20 0.43
RET P07949 2/20 0.43
PRKACA P17612 2/20 0.43
CSNK1A1 P48729 2/20 0.43
GSK3B P49841 2/20 0.43
CDK5 Q00535 2/20 0.43
ROCK1 Q13464 2/20 0.43
DYRK1A Q13627 2/20 0.43
ABL1 P00519 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18360948 0.82 MAP4K4 (0.49) KDRTAOK1MAP4K4CLK2GSK3A
SCHEMBL900339 0.82 MAPT (0.43) KDRMAP4K4CLK2RPS6KA3MAP4K2
SCHEMBL900471 0.77 PAK1 (0.47) L3MBTL1CSNK2A1
SCHEMBL1901292 0.70 MAP4K4 (0.53) KDRTAOK1MAP4K4CLK2GSK3A
SCHEMBL869609 0.68 KDR (0.54) KDRTAOK1MAP4K4CLK2GSK3A
SCHEMBL595121 0.68 GPR35 (0.43) LCKMAPK14
SCHEMBL737293 0.67 PI4KA (0.43) KDRPI4KAPI4K2BPI4K2API4KB
SCHEMBL15743366 0.66 KDR (0.53) KDRTAOK1MAP4K4CLK2GSK3A
SCHEMBL18590960 0.66 MAP4K4 (0.49) KDRTAOK1MAP4K4CLK2GSK3A
SCHEMBL6926673 0.66 KDR (0.49) KDRTAOK1MAP4K4CLK2GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012044993-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING OR PREVENTING NEURODEGENERATIVE DISEASES OR DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2012-04-05 WO disclosed